[Federal Register Volume 89, Number 83 (Monday, April 29, 2024)]
[Notices]
[Pages 33373-33374]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09047]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory 
Board (DTAB) will convene in open session in person and via web 
conference on June 4th, 2024, from 10:00 a.m. EST to 5:00 p.m. EST and 
in closed session on June 5th, 2024 from 9:00 a.m. EST to 12:00 p.m. 
EST.
    The board will meet in open-session June 4, 2024, from 10:00 a.m. 
EST to 5:00 p.m. EST to discuss the Mandatory Guidelines for Federal 
Workplace Drug Testing Programs, hear updates from the Nuclear 
Regulatory Commission, and discuss the availability of FDA 510(k) 
cleared assays and urine verses oral fluid prevalence data and specimen

[[Page 33374]]

validity and biomarker testing. Presentations include one by Faye 
Caldwell on industry moving parts pertaining to Oral Fluid 
implementation and another by Dr. Edward Cone regarding Johns Hopkins 
University study updates.
    The board will meet in closed session on June 5, 2024, from 9:00 
a.m. EST to 12:00 p.m. EST to discuss specimen validity testing data, 
challenges to Oral Fluid testing and the status of the Hair Mandatory 
Guidelines. All of these topics require input and discussion from Board 
Members as to the next steps of Federal Workplace Drug Testing. The 
DTAB meeting on June 5, 2024, from 9:00 a.m. EST to 12:00 p.m. EST, is 
closed to the public, as determined by the Assistant Secretary for 
Mental Health and Substance Use, SAMHSA, in accordance with 5 U.S.C. 
552b(c)(9)(B) and 5 U.S.C. App. 2, Section 10(d).
    Meeting registration information can be completed at https://snacregister.samhsa.gov/. Web conference and call information will be 
sent after completing registration. Meeting information and a roster of 
DTAB members may be obtained by accessing the SAMHSA Advisory 
Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings, or by contacting the Designated Federal Officer, Lisa Davis.
    Committee Name: Substance Abuse and Mental Health Services 
Administration Center for Substance Abuse Prevention Drug Testing 
Advisory Board.
    Dates/Time/Type: June 4, 2024, from 10:00 a.m. EST to 5:00 p.m. 
EST: OPEN; June 5, 2024, from 9:00 a.m. EST to 12:00 p.m. EST: CLOSED.
    Place: Substance Abuse and Mental Health Services Administration, 
5600 Fishers Lane, Rockville, MD 20857.
    To Submit Comments: Please send comments in writing at least 7 days 
prior to the meeting to the to the following email: 
[email protected].
    Contact: Lisa S. Davis, M.S, Social Science Analyst, Center for 
Substance Abuse Prevention, 5600 Fishers Lane, Rockville, Maryland 
20857, Telephone: (240) 276-1440, Email: [email protected].

Anastasia Flanagan,
Public Health Advisor, Division of Workplace Programs.
[FR Doc. 2024-09047 Filed 4-26-24; 8:45 am]
BILLING CODE 4162-20-P